Cost Effectiveness of Secukinumab Versus Other Biologics and Apremilast in the Treatment of Active Psoriatic Arthritis in Germany

[featured_image]
  • Version
  • Download 412
  • File Size 0.00 KB
  • File Count 1
  • Create Date 1. January 2019
  • Last Updated 13. July 2023

Cost Effectiveness of Secukinumab Versus Other Biologics and Apremilast in the Treatment of Active Psoriatic Arthritis in Germany

Attached Files

FileAction
s40258-019-00523-1Download